发明名称 QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY
摘要 <p>The present invention relates to quinazoline containing zinc-binding moiety based derivatives of Formula (IV) below. These compounds have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and are useful in the treatment of EGFR-TK related diseases and disorders such as cancer. These compounds may further act as HDAC inhibitors.</p>
申请公布号 EP2061773(A2) 申请公布日期 2009.05.27
申请号 EP20070842116 申请日期 2007.09.10
申请人 CURIS, INC. 发明人 QIAN, CHANGGENG;CAI, XIONG;GOULD, STEPHEN;ZHAI, HAIXIAO
分类号 A61K31/517;A61P35/00;C07D239/94;C07D401/12;C07D403/12;C07D405/04;C07D405/12;C07D409/12 主分类号 A61K31/517
代理机构 代理人
主权项
地址